Pfizer files for US approval for Omicron booster for kids
If the FDA authorizes the vaccine, the shot will still need another green light from the Centers for Disease Control and Prevention, the country's main federal health agency, before the first injections can be administered to children.
PREMIUMWorld
A health worker prepares a dose of the Pfizer-BioNTech vaccine against the novel coronavirus disease COVID-19, at a vaccination centre in Bogota, on January 19, 2022. (AFP)
NewVision Reporter
@NewVision
#Pfizer #Omicron booster #Children
Pfizer and BioNTech have asked United States health officials to authorize their Omicron-targeting Covid booster vaccine for children aged 5 to 11, the companies said Monday.